chrX-44242253-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_025184.4(EFHC2):c.1148C>T(p.Pro383Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,206,325 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000010 ( 0 hom. 1 hem. )
Consequence
EFHC2
NM_025184.4 missense
NM_025184.4 missense
Scores
5
10
Clinical Significance
Conservation
PhyloP100: 2.03
Genes affected
EFHC2 (HGNC:26233): (EF-hand domain containing 2) This gene encodes a protein which contains three DM10 domains and three calcium-binding EF-hand motifs. A related protein is encoded by a gene on chromosome 6. It has been suggested that both proteins are involved in the development of epilepsy (PMID: 15258581, 16112844) and that this gene may be associated with fear recognition in individuals with Turner syndrome. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFHC2 | NM_025184.4 | c.1148C>T | p.Pro383Leu | missense_variant | 8/15 | ENST00000420999.2 | NP_079460.2 | |
EFHC2 | XM_047442535.1 | c.1148C>T | p.Pro383Leu | missense_variant | 8/14 | XP_047298491.1 | ||
EFHC2 | XM_047442536.1 | c.1148C>T | p.Pro383Leu | missense_variant | 8/15 | XP_047298492.1 | ||
EFHC2 | XM_006724562.3 | c.560C>T | p.Pro187Leu | missense_variant | 7/14 | XP_006724625.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFHC2 | ENST00000420999.2 | c.1148C>T | p.Pro383Leu | missense_variant | 8/15 | 1 | NM_025184.4 | ENSP00000404232.2 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111494Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33674
GnomAD3 genomes
AF:
AC:
2
AN:
111494
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33674
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000115 AC: 2AN: 173959Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 60499
GnomAD3 exomes
AF:
AC:
2
AN:
173959
Hom.:
AF XY:
AC XY:
0
AN XY:
60499
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000100 AC: 11AN: 1094831Hom.: 0 Cov.: 30 AF XY: 0.00000277 AC XY: 1AN XY: 360657
GnomAD4 exome
AF:
AC:
11
AN:
1094831
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
360657
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111494Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33674
GnomAD4 genome
AF:
AC:
2
AN:
111494
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33674
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.1148C>T (p.P383L) alteration is located in exon 8 (coding exon 8) of the EFHC2 gene. This alteration results from a C to T substitution at nucleotide position 1148, causing the proline (P) at amino acid position 383 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Benign
T
REVEL
Benign
Sift4G
Uncertain
T
Polyphen
B
Vest4
MutPred
Loss of glycosylation at P383 (P = 0.0113);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -15
Find out detailed SpliceAI scores and Pangolin per-transcript scores at